AKT1 and ovarian carcinoma: In meta-analyses, p-AKT overexpression was also associated with worse survival in NSCLC (non-small cell lung carcinoma) [114,115], lymph node metastasis and poor prognosis in patients with gastric cancer [116], and poor overall survival and progression-free survival in patients with epithelial ovarian cancer [117].